Skip to main content

AgoraSign in

Nicole Malliotakis

Sponsor · U.S. Representative, NY-11 · Republican

Follow

House bill · H.R. 5197 (119th Congress)

Protect Beneficiaries from Middlemen Act

Latest action Sep 8, 2025

Summary

Protect Beneficiaries from Middlemen Act This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit and Medicare Advantage. Specifically, for costs above the deductible but below the annual out-of-pocket threshold, the bill limits cost-sharing to the average net price of the drug (i.e., the average amount paid less any rebates) or the cash price (i.e., the price charged to an individual without insurance), whichever is lower. The Government Accountability Office must report on the bill's implementation.

Your position on this bill

Not chosen yet

Sign in to choose

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Also referred to House Committee on Ways and Means · U.S. House of Representatives.

Full history

  1. Sep 8, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Sep 8, 2025

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Sep 8, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Sep 8, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Sep 8, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

About this record

Summary

The summary is written by the Congressional Research Service. For more, see How we handle summaries.

Source

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Read the record

Follow